Love Pharma Inc (CSE:LUV) has announced a change in its name to Jolt Health Inc to reflect its expanded focus on the wellness market beyond sexual health, with the change effective at the start of trading on May 22, 2023, when its shares will trade under the new symbol JOLT.
The company said its management feels that with the new name it will be easier to branch out into other areas of the wellness market with an increased focus on biotechnology, healthcare technology and the potential uses and applications of artificial intelligence.
In a statement, Jolt Health’s CEO and director, Zachary Stadnyk, commented: “We are excited to announce our name change and rebranding to Jolt Health. Our new name better reflects our company’s commitment to developing innovative technologies that have the potential to disrupt the healthcare industry."
He added: "We are focused on expanding our portfolio of health solutions, including further research into transdermal patch continuous delivery for FDA-approved pharmaceutical drugs, such as the previously announced interest in transdermal naltrexone, as well as other potential biotech solutions. Given the pace the world is changing at, we plan to further investigate utilizing AI in our solutions to enhance efficiencies and shareholder value.”
Love Pharma was founded in 2020, with a mission to bring to market innovative products that enhance sexual health and wellness while providing an improved quality of life. The company holds exclusive licenses to produce market, package, sell, and distribute patent-protected therapeutic and pharmaceutical products throughout Europe, the United Kingdom, and North America.
Contact the author at jon.hopkins@proactiveinvestors.com